Streamline Health Solutions (NASDAQ:STRM) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note released on Friday morning. The firm issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Stock Down 3.1 %

STRM opened at $1.94 on Friday. Streamline Health Solutions has a 12 month low of $1.92 and a 12 month high of $9.75. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 0.66. The business’s 50-day moving average price is $4.55 and its 200-day moving average price is $5.71. The company has a market cap of $120.26 million, a P/E ratio of -6.06 and a beta of 1.60.

Streamline Health Solutions (NASDAQ:STRM) last announced its quarterly earnings data on Wednesday, September 11th. The company reported ($0.75) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The company had revenue of $4.48 million during the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.